| 2-DG | 2-deoxyglucose |
| ACE | angiotensin-converting enzyme |
| AChR | acetylcholine receptor |
| AGX1 and 2 | alanine–glyoxylate aminotransferase 1 |
| AKT/PKB | protein kinase B |
| AMDHD2 | N-acetylglucosamine deacetylase |
| AML | acute myeloid leukemia |
| AMPK | AMP-activated protein kinase |
| ATF4 | activating transcription factor 4 |
| ATF6 | activating transcription factor 6 |
| ATP | adenosine triphosphate |
| AUF1 | AU-rich element RNA-binding protein 1 |
| BAD | BCL2 Associated Agonist of Cell Death |
| Bcl-xL | B-cell lymphoma-extra large |
| CD8-ISP | CD8-immature single positive |
| CDG | congenital disorders of glycosylation |
| ChREBP | carbohydrate-response element-binding protein |
| CMS | congenital myasthenic syndrome |
| CNS | central nervous system |
| COPII | coat complex II |
| CRC | colorectal cancer |
| CRPC | castration-resistant prostate cancer |
| CSC | cancer stem cells |
| CTP | cytidine triphosphate |
| DLBCL | diffuse large B-cell lymphoma |
| DN | double negative |
| DN3-DN4 | double negative 3 and double negative 4 |
| dNTP | deoxynucleotide triphosphate |
| DON | 6-Diazo-5-oxo-L-norleucine |
| DPAGT1 | UDP-GlcNAc: dolichol phosphate N-acetylglucosaminephosphotransferase 1 |
| DUF | domain with unknown function |
| EAE | experimental autoimmune encephalomyelitis |
| ECM | extracellular matrix |
| EGFR | epidermal growth factor receptor |
| eIF2α | eukaryotic initiation factor-2-α |
| EMT | epithelial–mesenchymal transition |
| ER | endoplasmic reticulum |
| ERAD | ER-associated protein degradation |
| Fbxl17 | F-box and leucine rich repeat protein 17 |
| FoxO1 | forkhead box O1 |
| Foxp3 | forkhead box P3 |
| Frc-6-P | fructose-6-phosphate |
| GalNAc1P | N-acetylgalactosamine-1-phosphate |
| GCK | glucokinase |
| GCN2 | general control non-depressible 2 |
| GDP-mannose | guanosine diphosphate mannose |
| GFAT/GFPT 1 and 2 | glutamine:fructose-6-phosphate amidotransferase 1 and 2 |
| GlcN-6-P | glucosamine-6-phosphate |
| GlcN/GAM | glucosamine |
| GlcNAc-1-P | N-acetylglucosamine-1-phosphate |
| GlcNAc-6-P | N-acetylglucosamine-6-phosphate |
| GlcNAc/NAG | N-acetylglucosamine |
| GLUT1 and 2 and 4 | glucose transporter 1 and 2 and 4 |
| GNPDA1 and 2 | glucosamine-6-phosphate deaminase 1 and 2 |
| GNPNAT1/GNA1 | glucosamine-6-phosphate N-acetyltransferase 1 |
| GPI | glycosylphosphatidylinositol |
| GPT | UDP-GlcNAc:dolichoylphosphate GlcNAc-1-phosphotransferase |
| GTK | glutamine transaminase K |
| HA | hyaluronan/hyaluronic acid |
| HBP | hexosamine biosynthetic pathway |
| HCC | hepatocellular carcinoma |
| HIF1α | Hypoxia-inducible factor 1-α |
| HRE | hypoxia response element |
| HUVEC | human umbilical vein endothelial cell |
| IL-13 | interleukin 13 |
| IL-4 | interleukin 4 |
| IL-7 | interleukin 7 |
| IL2R | interleukin-2 receptor |
| IRE1 | Inositol-requiring enzyme 1 |
| IRS-1 | insulin receptor substrate 1 |
| ISO | isoproterenol |
| ISR | integrated stress response |
| KL NSCLC | keratinizing squamous cell carcinoma of the non-small cell lung cancer |
| KRAS | Kirsten rat sarcoma virus |
| LARS1 | leucyl-tRNA synthetase 1 |
| LKB1 | liver kinase B1 |
| LND | lonidamine |
| LPS | lipopolysaccharides |
| LUAD | lung adenocarcinoma |
| LUSC | lung squamous cell carcinoma |
| LXR | liver receptor X |
| MEF | mouse embryonic fibroblasts |
| mESC | murine embryonic stem cells |
| MPNST | malignant peripheral nerve sheath tumor |
| mRNA | messenger RNA |
| MS | multiple sclerosis |
| mTOR | mechanistic target of rapamycin |
| mTORC1 and 2 | mTOR complex 1 and 2 |
| MYBL1 | MYB proto-oncogene-like 1 |
| NAGK | N-acetylglucosamine kinase |
| NF-κB | nuclear factor kappa B |
| NK | natural killer |
| NKT | NK T cells |
| NR4A1 | nuclear receptor subfamily 4 group A member 1 |
| NSCLC | non-small cell lung cancer |
| OGA | O-GlcNAcase |
| OGT | O-GlcNAc transferase |
| OxPhos | oxidative phosphorylation |
| PCK1 | phosphoenolpyruvate carboxykinase 1 |
| PD1 | programmed cell death protein 1 |
| PDAC | pancreatic ductal adenocarcinoma |
| PDK1 | pyruvate dehydrogenase kinase 1 |
| PERK | protein kinase R-like endoplasmic reticulum kinase |
| PFK1 | phosphofructokinase 1 |
| PGC1α | PPARG coactivator 1 α |
| PGM3 | phosphoglucomutase 3 |
| PI3K | phosphoinositide 3-kinases |
| PKA | protein kinase A |
| PKM2 | pyruvate kinase M2 |
| PKR | double-stranded RNA-activated protein kinase |
| PMM2 | phosphomannomutase 2 |
| polyQ | polyglutamine |
| PTEN | phosphatase and tensin homolog |
| REDD1 | regulated in development and DNA damage responses 1 |
| RNR | ribonucleotide reductase |
| ROS | reactive oxygen species |
| SEMD | spondylo-epi-metaphyseal dysplasia |
| SIN1 | stress-activated protein kinase |
| SLP-2 | stomatin-like protein 2 |
| SP | single positive |
| Sp1 | specificity protein 1 |
| SRPK2 | serine-/arginine-rich protein kinase 2 |
| STAT3 and 5 | signal transducer and activator of transcription 3 and 5 |
| TA | tubular aggregates |
| TAB1 | transforming growth factor-β-activated kinase-binding protein 1 |
| TCR | T cell receptor |
| TH | T helper |
| Th1 and Th2 | T helper type 1 and 2 |
| TLR4 and 2 | toll-like receptor 4 and 2 |
| TM | tunicamycin |
| TME | tumor microenvironment |
| Treg | T regulatory |
| tRNA | transfer RNA |
| TTLL5 | tubulin-tyrosine ligase-like 5 |
| UAP1 | UDP-N-acetylhexosamine pyrophosphrylase 1 |
| UC | ulcerative colitis |
| UDP-GalNAc | uridine diphosphate-N-acetyl galactosamine |
| UDP-GlcNAc | uridine diphosphate-N-acetyl glucosamine |
| UDP-HexNAc | uridine diphosphate N-acetyl hexosamine |
| UPR | unfolded protein response |
| UTP | uridine triphosphate |
| VCP | valosin-containing proteins |
| VEGF | vascular endothelial growth factor |
| Xbp1s | spliced x-box-binding protein 1 |